Opinions
Ryan Irvine
Pyng Medical Corp.
PYT-X
HOLD
Jan 16, 2008
Have a technology that delivers vital fluids to a patient in an emergency situation. Tremendous growth in earnings last year, up to about 4 1/2 cents per share. Has some lumpiness in its earnings traditionally. Good growth profile 1 to 2 years out.
$0.570
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Advertising